Your browser doesn't support javascript.
loading
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.
Yuan, Yuan; Lee, Jin Sun; Yost, Susan E; Li, Sierra Min; Frankel, Paul H; Ruel, Christopher; Schmolze, Daniel; Robinson, Kim; Tang, Aileen; Martinez, Norma; Stewart, Daphne; Waisman, James; Kruper, Laura; Jones, Veronica; Menicucci, Andrea; Uygun, Sahra; Yoder, Erin; van der Baan, Bastiaan; Yim, John H; Yeon, Christina; Somlo, George; Mortimer, Joanne.
Afiliação
  • Yuan Y; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Lee JS; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Yost SE; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Li SM; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Frankel PH; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Ruel C; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Schmolze D; Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Robinson K; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Tang A; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Martinez N; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Stewart D; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Waisman J; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Kruper L; Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Jones V; Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Menicucci A; Agendia Precision Oncology, Irvine, California, USA.
  • Uygun S; Agendia Precision Oncology, Irvine, California, USA.
  • Yoder E; Agendia Precision Oncology, Irvine, California, USA.
  • van der Baan B; Agendia Precision Oncology, Irvine, California, USA.
  • Yim JH; Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Yeon C; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Somlo G; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Mortimer J; Department of Medical Oncology and Therapeutic Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Oncologist ; 26(3): e382-e393, 2021 03.
Article em En | MEDLINE | ID: mdl-33098195
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos